RPC Pharma Ltd → Akari Therapeutics Plc AKTX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

5,810 shares short · -96.6% vs prior

Other 13D/G Filings on Akari Therapeutics Plc

Filed	Form	Filer	Stake	Shares
2025-02-14	SCHEDULE	Prudo-Chlebosz Raymond	9.30%	4,926,600,800	view →
2024-01-04	SC	RPC Pharma Ltd	—	—	view →
2022-01-14	SC	RPC Pharma Ltd	—	—	view →
2021-10-18	SC	RPC Pharma Ltd	—	—	view →

Other Filings by RPC Pharma Ltd

Filed	Form	Issuer	Stake	Shares
2024-01-04	SC	Akari Therapeutics Plc AKTX	—	—	view →
2022-01-14	SC	Akari Therapeutics Plc AKTX	—	—	view →
2021-10-18	SC	Akari Therapeutics Plc AKTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →